Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ong-term Oncologic Outcome of Breast-conserving Surgery in Breast Cancer Patients With BRCA1/2 Mutations

NCT06429644 is registered in ClinicalTrials.gov with Hanyang University Seoul Hospital as lead sponsor.

NCT NCT06429644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06429644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ong-term Oncologic Outcome of Breast-conserving Surgery in Breast Cancer Patients With BRCA1/2 Mutations
Lead sponsor
Hanyang University Seoul Hospital
Phase
Observational
Overall status
Completed
Start date
July 7, 2022
Completion date
April 8, 2024
Enrollment
4,010 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca1/2 mutation, breast-conserving surgery